首页> 外文期刊>Biophysical Chemistry: An International Journal Devoted to the Physical Chemistry of Biological Phenomena >Binding kinetics of mutant p53R175H with wild type p53 and p63: A Surface Plasmon Resonance and Atomic Force Spectroscopy study
【24h】

Binding kinetics of mutant p53R175H with wild type p53 and p63: A Surface Plasmon Resonance and Atomic Force Spectroscopy study

机译:野生型P53和P63的突变体P53R175H的结合动力学:表面等离子体共振和原子力光谱研究

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract The oncogenic mutant p53R175H, one of the most frequently occurring in human cancers and usually associated with poor prognosis and chemo resistance, can exert a dominant negative effect over p53 family members, namely wild type p53, p63 and p73, inhibiting their oncosuppressive function. Novel anticancer strategies based on drugs able to prevent the formation of complexes between p53R175H and the p53 family members call for a deeper knowledge on the molecular mechanisms of their interaction. To this aim, p53R175H/p63 and p53R175H/p53 complexes were investigated in vitro by using Surface Plasmon Resonance and Atomic Force Spectroscopy, two emerging and complementary techniques able to provide interaction kinetic information, in near physiological conditions and without any labelling. Both approaches show that p53R175H forms a very specific and highly stable bimolecular complex with both p63 and p53; with these interactions being characterized by a very high affinity with equilibrium dissociation constant, K D , of about 10 ? 9 M. These kinetics results, discussed also in connection with those previously reported for the interaction of p53R175H with p73, could inspire the design of suitable anticancer drugs able to antagonize the interaction of p53R175H with the p53 family members, by restoring then their anti-tumour function. Graphical abstract Display Omitted Highlights ? SPR and AFS monitored the high affinity complex of p53R175H and p53wt or p63. ? Mutant p53R175H interacts with all p53 family (p53, p63 and p73) with high affinity. ? Measured kinetics are insightful to drug design inhibiting these complexes.
机译:摘要致癌突变体P53R175H,最常发生的人类癌症中的一种,通常与预后差和化学抗性有关,可以对P53家族成员进行显着的负面影响,即野生型P53,P63和P73,抑制其肿瘤抑制功能。基于药物的新型抗癌策略,能够防止P53R175H和P53家庭成员在P53R175H和P53家庭成员之间形成综合的综合作用的更深知识。为了通过使用表面等离子体共振和原子力光谱,两个新出现和互补技术,在近生理条件下和没有任何标签的情况下,通过使用表面等离子体共振和原子力光谱来研究P53R175H / P63和P53R175H / P53复合物。两种方法表明,P53R175H与P63和P53都形成非常特异的和高度稳定的双分子复合物;这些相互作用的特征在于具有非常高的亲和力,与平衡解离常数,K D约10?这些动力学结果也与先前报道的P53R175H与P73相互作用的那些进行讨论,可以激发合适的抗癌药物的设计,该设计能够通过恢复的抗-P53家族成员拮抗P53R175H的相互作用。肿瘤功能。图形抽象显示省略了亮点? SPR和AFS监测P53R175H和P53WT或P63的高亲和力复合物。还突变体P53R175H以高亲和力的所有P53家族(P53,P63和P73)相互作用。还测量的动力学对药物设计抑制这些复合物的洞察力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号